Rufus W. Burlingame
Rufus W. Burlingame publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research and T-cell and B-cell Immunology.
- World rank
- #1,384,797 of 7,710,434 ranked researchers
- Rank in United States
- #437,813 of 1,627,098
- Works
- 72
- Citations
- 3.7k
- Citations per work
- 51.0
What does Rufus W. Burlingame research?
Rufus W. Burlingame's work is mostly in Medicine (47%), Immunology and Microbiology (15%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3446.8%
- Medicine3446.8%
- Everything else2027.4%
- Life Sciences1925.8%
- 1Rheumatology24% of their works
- 2Immunology15% of their works
- 3Radiology, Nuclear Medicine and Imaging11% of their works
- 4Molecular Biology10% of their works
- 5Pathology and Forensic Medicine7% of their works
- 6Hematology4% of their works
Research topics
- Systemic Lupus Erythematosus Research
- Monoclonal and Polyclonal Antibodies Research
- T-cell and B-cell Immunology
- Rheumatoid Arthritis Research and Therapies
- Autoimmune and Inflammatory Disorders Research
- Systemic Sclerosis and Related Diseases
- Atherosclerosis and Cardiovascular Diseases
- Genomics and Chromatin Dynamics
Which keywords describe Rufus W. Burlingame's research?
The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Fc Receptors, Therapeutic Antibodies, Cytokines, Inflammation and Foxp3.
- Chromatin
- Atherosclerosis
- Juvenile Idiopathic Arthritis
- Fibrosis
- Biological Therapy
- Foxp3
- Cytokines
- Fc Receptors
- Antiphospholipid Syndrome
- Autoantibodies
- Systemic Lupus Erythematosus
- Therapeutic Antibodies
- Inflammation
- TGF-ß
- Rheumatoid Arthritis
- Hemophagocytic Lymphohistiocytosis
- Systemic Sclerosis
- Immune Response
- Transcription
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies513 topics
- Antiphospholipid Syndrome291 topic
- Systemic Lupus Erythematosus291 topic
- Fc Receptors221 topic
- Therapeutic Antibodies221 topic
- Cytokines212 topics
- Inflammation212 topics
- Foxp3171 topic
- TGF-ß171 topic
- Biological Therapy151 topic
- Rheumatoid Arthritis151 topic
- Fibrosis71 topic
- Hemophagocytic Lymphohistiocytosis71 topic
- Juvenile Idiopathic Arthritis71 topic
- Systemic Sclerosis71 topic
- Atherosclerosis61 topic
- Immune Response61 topic
- Chromatin51 topic
- Transcription51 topic
Where does Rufus W. Burlingame work?
Rufus W. Burlingame's main affiliation in the publication record is Nova Medical (United States), United States.
How many publications and citations does Rufus W. Burlingame have?
OpenAlex counts 72 works and 3,674 citations for Rufus W. Burlingame, an h-index of 29, ranking #1,384,797 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rufus W. Burlingame. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.